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ABSTRACT 25 
BACKGROUND/OBJECTIVES: Obesity is common following hypothalamic damage due to tumours. 26 
Homeostatic and non-homeostatic brain centres control appetite and energy balance but their interaction in 27 
the presence of hypothalamic damage remains unknown. We hypothesized that abnormal appetite in obese 28 
patients with hypothalamic damage results from aberrant brain processing of food stimuli. We sought to 29 
establish differences in activation of brain food-motivation and reward neurocircuitry in patients with 30 
hypothalamic obesity (HO) compared to patients with hypothalamic damage whose weight had remained 31 
stable. 32 
SUBJECTS/METHODS: In a cross-sectional study at a University Clinical Research Centre, we studied 9 33 
patients with HO, 10 age-matched obese controls (OC), 7 patients who remained weight-stable following 34 
hypothalamic insult (HWS), and 10 non-obese controls (NOC).  Functional magnetic resonance imaging was 35 
performed in the fasted state, 1 h and 3 h after a test meal, while subjects were presented with images of 36 
high-calorie foods, low-calorie foods and non-food objects. Insulin, GLP-1, PYY and ghrelin were measured 37 
throughout the experiment and appetite ratings recorded. 38 
RESULTS: Mean neural activation in the posterior insula and lingual gyrus (brain areas linked to food 39 
motivation and reward value of food) in HWS were significantly lower than in the other 3 groups (P = 40 
0.001). A significant negative correlation was found between insulin levels and posterior insula activation (P 41 
= 0.002). 42 
CONCLUSIONS: Neural pathways associated with food motivation and reward-related behaviour, and the 43 
influence of insulin on their activation, may be involved in the pathophysiology of HO. 44 
 45 
 46 
 47 
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INTRODUCTION 48 
Weight gain and obesity are common sequelae of hypothalamic damage secondary to e.g. hypothalamic 49 
tumours or craniopharyngiomas.1,2 Hypothalamic obesity (HO) is an acute weight gain following such 50 
damage despite adequate treatment of associated hormone deficiencies, and is typically clinically significant, 51 
difficult to predict and refractory to treatment. The neurobiology of HO remains unclear. 52 
Control of appetite depends on interacting homeostatic and non-homeostatic (cognition, emotion and reward) 53 
systems.3 The main homeostatic brain regions regulating feeding and body weight are the hypothalamus, 54 
brainstem (especially the midbrain ventral tegmental area [VTA]) and nucleus accumbens, while the cortico-55 
limbic and higher cortical regions are important in the processing of environmental cues, the hedonic drive to 56 
eat and the rewarding properties of food. The interactions between these two systems in humans remain 57 
poorly characterized. Functional brain imaging (fMRI) has been used to explore these by identifying brain 58 
areas that are differentially activated by alteration of the feeding state under different clinical and 59 
experimental conditions.  60 
We hypothesized that abnormal appetite in HO results from aberrant processing of food stimuli in the neural 61 
pathways that guide reward-related behaviour, and which may assume a dominant role following 62 
hypothalamic damage. Our main objective was to establish differences in activation of food-motivation and 63 
reward neurocircuitry in HO compared to patients whose weight had remained stable following 64 
hypothalamic injury, using fMRI to measure brain responses to visual food stimuli before and after a 65 
standardized meal.  66 
 67 
SUBJECTS AND METHODS 68 
Participants 69 
We studied 36 participants: 9 obese patients with hypothalamic damage (HO), 7 weight-stable non-obese 70 
patients with hypothalamic damage (HWS), and 20 healthy BMI-matched volunteers [10 non-obese controls 71 
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(NOC) and 10 obese controls (OC)] of similar age and sex. Our study protocol approved by the Northwest 72 
Research Ethics Committee, (09/H1001/4) had the following exclusion criteria for all participants: history of 73 
eating disorder, psychiatric disorder , diabetes mellitus (type 1 or 2), current (or within last 3 months) use of 74 
certain centrally acting medication (such as psychotropic or antidepressant medication, sibutramine, 75 
rimonabant that are known to influence feeding behaviour), history of traumatic brain injury, current history 76 
of excess alcohol consumption, genetic forms of hypothalamic obesity (such as Prader-Willi syndrome, 77 
Biedl-Bardet syndrome) and current history of substance abuse or addiction. Patients were recruited from 78 
specialist neuroendocrine clinics in Liverpool, UK. All had undergone treatment for hypothalamic tumours 79 
or adjacent tumours compressing or invading the hypothalamus which included 9 pituitary macroadenomas, 80 
6 craniopharyngiomas and 1 hypothalamic glioma, with grade 2 hypothalamic damage (Saint-Rose C et al. 81 
grading) determined by a neuroradiologist. HO was defined as body mass index (BMI) ≥30 kg/m2 at latest 82 
clinical follow-up which had increased 2 kg/m2 since tumour diagnosis. HWS patients had BMI <30 kg/m2 83 
which had not increased >2 kg/m2 since diagnosis. All patients were on adequate pituitary hormone 84 
replacement therapy; based on standard dynamic endocrine testing 12 patients had cortisol deficiency and 85 
were receiving hydrocortisone, 10 had secondary hypothyroidism treated with thyroxine and 6 had 86 
permanent central diabetes insipidus treated with desmopressin; all pre-menopausal women with secondary 87 
hypogonadism were on hormone replacement therapy and 6 hypogonadal male patients were treated with 88 
testosterone. Fourteen patients had severe growth hormone deficiency of whom 12 were receiving 89 
replacement therapy, the other two, being asymptomatic as assessed by the QOL-AGHDA questionnaire, did 90 
not qualify for treatment under UK guidelines. Healthy volunteers were recruited by advertisement and 91 
categorised as obese if BMI ≥30 kg/m2. Written informed consent was obtained from each participant.  92 
 93 
Study design  94 
Participants fasted from 2200 the previous night and underwent fMRI at 0900. Blood samples were collected 95 
before the baseline scan, following which participants consumed a breakfast meal of porridge and orange 96 
juice constituting 25% of calculated basal metabolic rate. fMRI was repeated 1 h after breakfast after which 97 
participants rested quietly for 2 h undergoing blood sampling and appetite assessment. fMRI was performed 98 
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again 3 h after breakfast. Blood samples were taken before and 15, 30, 60, 120 and 180 min after breakfast 99 
and at the end of all scanning, for measurement of insulin, glucagon-like peptide-1 (GLP-1), ghrelin, and 100 
Peptide YY (PYY). Visual Analogue Scale (VAS) ratings of hunger, fullness, and desire to eat were 101 
completed by the participants in the fasting state and at the end of each scanning session.  102 
 103 
MRI acquisition 104 
MR images were obtained using a Siemens 3 Tesla Trio (Erlangen, Germany) and eight-channel head coil. 105 
fMRI used echoplanar EPI (TR 3000 ms, TE 30 ms, flip angle 90˚, FOV 192×192 mm2, 56 oblique 2 mm 106 
slices with slice gap 0.8 mm, voxel 3×3×3 mm3). Whole brain anatomical T1-weighted MRI used MDEFT 107 
(TR7.92 ms, TE 2.48 ms, flip angle 16˚, FOV 256×240, 180 1mm slices, voxel 1×1×1 mm3). 108 
 109 
fMRI activation task 110 
The task presented images of high-calorie foods (e.g. sausage rolls, doughnuts), low-calorie foods (e.g. 111 
steamed salmon with vegetables, mixed fruit salad) or non-food objects (e.g. shoes, toy cars, cycle helmet). 112 
Food photographs were included based on a questionnaire where participants were asked if the food shown 113 
was high or low energy, and to rate its pleasantness (hedonic value); photographs included were those with 114 
the greatest agreement on energy content and judged the most pleasant. Images were presented using 115 
Presentation software (https://nbs.neuro-bs.com). Each block of 4 lasted 16 s and consisted of either high-116 
calorie foods, low-calorie foods, or non-food objects, with a 6 s rest period showing a fixation cross between 117 
blocks. Each condition (high-calorie foods, low-calorie foods, objects) appeared once per cycle in random 118 
order, for a total of 8 cycles, with no duplication of images (Figure 1).  119 
 120 
Image analysis  121 
Pre-processing and statistical analyses used SPM8 (Statistical Parametric Mapping software package, 122 
Wellcome Department of Cognitive Neurology, London, UK: http://www.fil.ion.ucl.ac.uk/spm). Slice-timing 123 
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correction was followed by realignment to correct for head movement. A mean functional image was 124 
constructed from the realigned images for each participant, and co-registered to the Montreal Neurological 125 
Institute (MNI) EPI template in SPM8. The resulting pixel size in standard stereotaxic coordinates was 2×2 126 
mm2, with interplane distance 2 mm. The normalized images were smoothed with an isotropic Gaussian 127 
kernel of 6×6×6 mm3 FWHM to compensate for variations in brain size and gyral pattern. 128 
Biochemical measurements 129 
All samples were assayed in duplicate in one batch. Blood for measurement of GLP-1, PYY and ghrelin was 130 
collected in tubes containing 50 µl aprotinin to prevent proteolytic degradation, centrifuged at -4°C and 131 
plasma stored for analysis at -80°C. Insulin was measured using a Siemens Immulite 2000 Immunoassay. 132 
Active GLP-1 and active ghrelin were measured using commercial enzyme-linked immunoassays (ELISA) 133 
(Millipore, Billerica, USA); the standard curve range for GLP-1 was 0.8-100 pmol/l and inter- and intra-134 
assay precisions were 8% and 7% respectively, while the corresponding range for ghrelin was 10-2000 pg/ml 135 
and inter- and intra-assay precisions were 10-16% and 7-10%. PYY (3-36) was measured using a 136 
commercial ELISA (Phoenix Pharmaceuticals Inc, Burlingame, USA); standard curve range was 0.06-100 137 
ng/ml. 138 
 139 
Statistical analyses 140 
The smoothed normalised functional images were included in the first level design matrix in SPM8. For each 141 
participant, the contrast between all foods and objects was selected to remove activation related to visual 142 
perception and object recognition. The resulting single contrast images (1 per participant) were entered into a 143 
one-sample t-test (second level analysis) to determine activation to all foods across all subjects. Results were 144 
corrected for multiple comparisons using a false discovery rate (FDR) of P≤0.05 and a cluster size of k ≥20. 145 
Regions of interest (ROIs) were defined using MarsBaR (http://marsbar.sourceforge.net/); only ROIs with 146 
cluster size k 3000 voxels were used in subsequent analysis. The 6 significant clusters are shown in Table 147 
1. Contrast values for high- and low-calorie foods in each of these 6 ROIs were defined using MarsBaR for 148 
each of the 3 sessions using each participant’s first level design matrix, generating 6 contrast values per 149 
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participant. Subsequent statistical analysis was performed in SPSS v.17. Six linear mixed-effects models 150 
were performed for the 6 activation clusters. For each, ROI contrast values for high- and low-calorie foods 151 
for each of the 3 sessions were entered as the outcome variable. The grouping factors weight stable 152 
(NOC+HWS) vs. obese (OC+HO), controls (NOC+OC) vs. patients (HWS+HO) and the interaction 153 
between these were entered as predictor variables along with the variables session (fasting, 1 h and 3 h post 154 
meal) and high/low-calorie foods. To analyse contributions of age, sex and other variables to effects of 155 
grouping factors, two-way analyses of covariance (ANCOVA) were performed with select brain activations 156 
as dependent measures and age, sex, PYY, BMI and VAS scores as covariates. 157 
Areas under the curve (AUC) for ghrelin, GLP-1, PYY and insulin responses were calculated by trapezoidal 158 
integration using GraphPad Prism-5 software. A linear mixed-effects model was performed using the 159 
outcome variable ghrelin AUC and the predictor variables weight-stable vs. obese group, control vs. patient 160 
group, and session (at 3 levels). Similar models were performed using outcome variables GLP-1 AUC, PYY 161 
AUC and insulin AUC and the VAS ratings hunger, fullness and desire to eat. P<0.05 (two-tailed) was taken 162 
as significant.  163 
 164 
RESULTS 165 
Nine patients with HO [mean (SD) BMI 37.7(5.4) kg/m2, age 47(15) y], 10 age-matched obese controls (OC) 166 
[BMI 38(6) kg/m2], 7 patients who remained weight-stable following hypothalamic insult (HWS) [BMI 167 
26.9(2.3) kg/m2, age 57(17) y], and 10 age-matched non-obese controls (NOC) [BMI 26(3) kg/m2] were 168 
studied. 169 
fMRI data 170 
Effects of picture types (high- and low-calorie foods, objects) 171 
 Across all participants and scanning sessions there were 6 ROIs with significantly greater activation for food 172 
images compared to objects (Table 2): left-hemisphere posterior insula and middle frontal gyrus, and right-173 
hemisphere lingual gyrus, precentral gyrus, anterior cingulate and posterior cingulate gyrus. Mean activation 174 
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across the 6 regions for high- and low-calorie foods is given for each of the 4 groups in Table 2. The 175 
activation maps are shown in Figure 2.  176 
No significant effect was found for high/low-calorie foods in any of the 6 linear mixed effects 177 
models (P>0.05). Potential interactions between patient/control group, lean/obese group and 178 
high/low-calorie foods were considered in each model by adding the product of the corresponding 179 
two variables as an additional explanatory variable; none significantly improved the fit (P>0.05) 180 
and were subsequently excluded. 181 
Between-group comparison 182 
In 5 of these 6 brain areas obese participants (HO+OC) showed greater activation in response to high-calorie 183 
foods than non-obese participants (HWS+NOC) (Table 2). Box plots for each of the 6 ROIs separated by 184 
patient/control and lean/obese group are shown in Figure 3.  185 
The linear mixed-effects model showed a significant difference in activation of the lingual gyrus (P=0.001; 186 
coefficient -0.34, SE 0.1, 95% CI: -0.53, -0.15) and posterior insula (P=0.001; coefficient -0.2, SE 0.06, 95% 187 
CI: -0.33, -0.08) between weight-stable (HWS+NOC) vs. obese (HO+OC) groups. The activation cluster 188 
in insula, having spatial maximum in posterior insula, also spread to middle insular cortex. The 189 
interaction between the groups weight-stable (HWS+NOC) vs. obese (HO+OC) and controls (NOC+OC) vs. 190 
patients (HO+HWS) was significant for lingual gyrus (P<0.001; coefficient 0.47, SE 0.13, 95% CI: 0.22, 191 
0.73) and posterior insula (P=0.028; coefficient 0.19, SE 0.08, 95% CI: 0.02, 0.35). Activation for both high- 192 
and low-calorie foods in lingual gyrus and posterior insula was weaker in HWS than in HO and controls 193 
(OC+NOC) (Table 3).  194 
None of the covariates (age, sex, PYY, BMI or VAS scores) showed significant covariation in either 195 
posterior insula or lingual gyrus. Further, the interaction effects were significant even with inclusion of 196 
covariates. We conclude that the interactions between weight-stable (HWS+NOC) vs. obese (HO+OC) and 197 
controls vs. patients seen in posterior insula and lingual gyrus were not caused by individual or group 198 
differences in age or other variables. 199 
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Post-hoc pair-wise comparisons were performed for the variable session (at 3 levels: fasted, 1 h and 3 h post-200 
meal) in each linear mixed-effects model. Session was significant for lingual gyrus (F(2, 138)=4.542, P=0.012), 201 
posterior insula (F(2,151)=3.024, P=0.05) and posterior cingulate gyrus (F(2,148)=3.556, P=0.03). Pair-wise 202 
comparisons revealed a significant difference in activation across posterior insula between the fasted state 203 
and 3 h post-meal (P=0.04; mean difference 0.12, SE 0.06, 95%CI: 0.004,0.23) and between 1 h and 3 h 204 
post-meal (P=0.05; mean difference 0.09, SE 0.05, 95%CI: -0.001,0.18), with greater activation in the fasted 205 
state and 1 h compared to 3 h post-meal. Across all groups, activation of the lingual gyrus in the visual 206 
cortex was greater fasted compared to 3 h post-meal (P=0.003; mean difference 0.24, SE 0.8, 95%CI: 0.08, 207 
0.40). Activation was weaker in the posterior cingulate gyrus in the fasted state compared to 1 h post-meal 208 
(P=0.012; mean difference -0.15, SE 0.06, 95%CI: -0.27,-0.034). 209 
The linear mixed-effects models showed a significant effect for control vs. patient group where ghrelin was 210 
the outcome variable (F(1,27)=5.245, P<0.03), with patients (HO+HWS) having higher ghrelin than controls 211 
(OC+NOC) (coefficient -1.06, SE 0.5, 95% CI: -2.0, -0.1); this group effect was not significantly associated 212 
with levels of PYY, GLP-1 or insulin (P>0.05). The effect weight-stable vs. obese group was statistically 213 
significant for the model where PYY was the outcome variable (F(1,27)=8.99, P=0.006), with obese 214 
individuals having higher PYY than weight-stable individuals (coefficient -0.24, SE 0.1, 95% CI: -0.4,-0.1); 215 
this group effect was not significantly associated with levels of GLP-1, ghrelin or insulin (P>0.05).  216 
 217 
Relationship between insula activation and hormonal parameters 218 
ANCOVA was used to assess activation across the insula cortex while controlling for ghrelin, GLP-1, PYY 219 
and insulin. Predictor variables were selected stepwise. Only insulin was significantly associated with 220 
posterior insula activation (P=0.04), with negative significant correlation between insulin level and posterior 221 
insula activation (ß = -0.004, P=0.002) such that a 1 U/l increase in insulin corresponds to a 0.004 decrease 222 
in insula activation. Insulin AUC for the four subject groups is shown in supplementary figure. 223 
 224 
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Appetite VAS ratings 225 
Results from the linear mixed-effects models showed higher VAS ratings for hunger (P<0.05; coefficient 226 
8.37, SE 4.3) and desire to eat (P=0.04; coefficient 9.01, SE 4.3, 95% CI: 0.45,17.6) in obese participants 227 
(HO+OC) compared to non-obese (HWS+NOC) throughout the whole experiment irrespective of presence 228 
of hypothalamic damage. 229 
 230 
DISCUSSION 231 
Viewing high-calorie food-related stimuli, weight-stable patients with hypothalamic damage (HWS) showed 232 
significantly less brain activation in regions linked to processing of interoceptive inputs and modulation of 233 
food motivation behaviour (e.g., the posterior and middle insula),4 and in regions linked to reward value for 234 
food (e.g the lingual gyrus). In patients with HO, enhanced activation of food motivation and reward 235 
neurocircuitry is accompanied by increased hunger and desire to eat, potentially influencing food-seeking 236 
behaviour and leading to higher food intake than patients who do not gain significant weight. In both these 237 
groups (HO and HWS) the hypothalamic centre of energy homeostasis is damaged. Our findings suggest that 238 
in the HWS patients there may be greater preservation of the functional and anatomical connectivity between 239 
the brain food reward processing network and the extra-hypothalamic homeostatic neurocircuitry (such as 240 
the midbrain VTA and the nucleus accumbens) allowing a more coordinated response between the 241 
homeostatic and reward networks that regulate feeding behaviour and energy balance. 242 
Of the 6 brain regions with significantly greater activation when viewing food images compared to objects, 2 243 
regions (insula and anterior cingulate cortex [ACC]) were first described in Tataranni’s seminal PET study 244 
of hunger and satiety in humans5 and have been identified in multiple studies since. The lingual gyrus 6 has 245 
also been identified as important in neuroimaging studies of obesity. Some of these regions determine the 246 
incentive/reward value of food,7,8,9 some are linked to meal termination5,10 and satiation,5 and some with 247 
liking.10 Further studies have shown differential activation patterns in these brain regions in obese compared 248 
to lean participants.11,15 Although the striatal region (dorsal and ventral striatum) has been identified 249 
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as an important area governing food intake and perception of food reward, we have not replicated 250 
this finding in accordance with other fMRI and PET studies. 3,4,7,9,13,15  251 
 The greater activation in the lingual gyrus (which has been linked to the reward value of food) we observed 252 
in response to high-calorie foods in all groups compared to HWS accords with a previous PET finding11 that 253 
obese males have greater decrease in regional cerebral blood flow in this region compared to lean following 254 
satiation with a liquid meal. Also consistent with our findings, Rothemund et al12 found increased activation 255 
in the left lingual gyrus (and also the insula) when viewing high-calorie foods, in obese compared to lean 256 
individuals.  257 
The posterior insular cortex is critical in appetite and feeding, and has connections with the thalamus,13,14 258 
hypothalamus,13 orbitofrontal cortex,14 prefrontal cortex (PFC) and amygdala. Posterior insula activity has 259 
been reported to increase with hunger5,8,9 and decrease with satiation11,15 and overfeeding16 by decreasing the 260 
perceived salience/reward value of food stimuli.10,17  261 
The insula promotes food intake and is inhibited by areas involved in meal termination, such as the PFC.11,15 262 
In our HWS group its connections with other important brain areas (especially the extra-hypothalamic 263 
homeostatic neurocircuitry such as the VTA and the nucleus accumbens) may have been better preserved 264 
following hypothalamic damage; this may explain the pattern of activation in insula in response to high-265 
calorie food stimuli, which is similar to the pattern previously observed, including in lean participants .11,15 266 
Our finding of greater insula activation in HO compared to HWS agrees with findings in obese compared to 267 
lean cohorts without hypothalamic damage.11,12,15,18  268 
 269 
The neurochemical/neuroendocrine processes underlying this differential pattern of brain activation in insula 270 
and lingual gyrus in patients who remain weight-stable compared with those who develop HO, remain 271 
speculative. The significant covariance effect between posterior insula activation decreases and increased 272 
insulin, which accords with a previous PET study,5 is suggestive. There is animal evidence that insulin acts 273 
centrally to reduce the reward properties of food,19 and intranasal insulin administration reduces food intake 274 
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in humans,20 suggesting that it may facilitate long-term regulation of food intake and energy balance by 275 
acting as an anorectic signal. Notably, insulin increases neuronal firing in the insula in rats,21 and intranasal 276 
insulin administration in healthy volunteers increases neuronal activation in the insula,22 a finding which 277 
differs from the present and previous studies,5 and points to a potential fractionation of brain responses to 278 
insulin in the absence of an adequate peripheral insulin response. Our findings suggest that the insula 279 
responds differently to insulin signals in weight-stable (HWS) and obese hypothalamic patients (HO). 280 
Although insulin levels were similar in both groups (supplementary figure), insular activation was greater in 281 
HO than HWS, perhaps suggesting a preserved negative association between plasma insulin level and insula 282 
activation in the latter. None of the changes of PYY, GLP-1 in the 4 groups were associated with the 283 
differential brain activation patterns observed in the 6 ROIs, and more specifically in the insula and lingual 284 
gyrus which emerged as the regions of hypoactivation in the HWS group. This does not support an 285 
aetiological role for these appetite and satiety-related signals in the pathogenesis of HO.  286 
PYY is a possible mediator of postprandial satiety. We have shown that HO patients have fasting levels of 287 
total PYY similar to obese controls,23 and fail to exhibit an immediate and sustained post-meal rise. 288 
Intriguingly, PYY levels were greater in the obese participants compared with the non-obese, in contrast to 289 
previous reports.24,25 Differences in experimental design, macronutrient and energy content of the test meals 290 
(which we based on individual calculated basal metabolic rate) may account for this disparity.  291 
Leptin acts on neural circuits governing food intake to diminish perception of food reward while enhancing 292 
the response to satiety signals.26,27 Although we found similar fasting leptin levels in HO and obese 293 
controls,23 it would be interesting to study differences in dynamic test-meal responses of circulating leptin 294 
between HO and HWS and their correlation with the differential patterns of activation in the insula and 295 
lingual gyrus. 296 
Our study has limitations. Previous studies have described a difference in insula activation between males 297 
and females following satiation,28 so our mixed gender groups may have obscured some differences between 298 
pre- and post-prandial time-points. Our stringent statistical threshold may have reduced the number of areas 299 
of significant between-group difference; however, it adds additional weight to our positive findings. We 300 
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also were not able to control for handedness or timing of menstruation in our female participants, 301 
due to the complex nature of the study groups involved. Ideally, we would have used a homogenous 302 
patient group, with one underlying histological diagnosis, but the limited numbers of patients seen in any 303 
single centre made it necessary to accept a more heterogeneous patient group.  304 
In keeping with all other fMRI studies, artefacts can cause lack of homogenous image quality in 305 
some brain regions. It was not possible to personalise the food photographs to an individual’s food 306 
preferences. Our study, however, used a reasonably physiological overnight fasting period, and the low- 307 
and high-calorie food photographs were of comparable hedonic value, taken on a standardized background, 308 
and with good visual variability. In summary, we have shown that neural pathways associated with food 309 
motivation and reward-related behaviour in response to food are differentially activated in patients with HO 310 
and in those who do not experience weight gain after hypothalamic damage. We have not been able to 311 
demonstrate in the small numbers of patients we have studied, correlation of meal initiation and termination 312 
signals such as ghrelin, PYY and GLP-1 with brain activation patterns, although we have shown that high 313 
plasma insulin levels correlated strongly with a reduction in the perceived reward properties of food. It is 314 
clear that the insula and lingual gyrus are an integral part of the network of brain areas involved in 315 
processing food stimuli. A comparatively weak posterior insula and lingual gyrus activation in the HWS 316 
patients may ‘protect’ these individuals from weight-gain. As this is a preliminary study reporting 317 
preliminary results, we are not suggesting a causal link between differential activation patterns of these 318 
regions and increased food intake; instead, we are shedding some light on potential disturbances of neuro-319 
circuitry that may underlie the pathogenesis of this complex entity hypothalamic obesity, which remains 320 
poorly understood and poorly prevented and managed. 321 
Disentangling the neurochemical/neuroendocrine processes underlying this differential pattern of brain 322 
activation in the insula and lingual gyrus may help in understanding the mechanisms underpinning weight-323 
gain both in HO and in simple obesity in the general population. Further research into the pathophysiology of 324 
weight-gain in this interesting group of patients is encouraged, potentially in a large multi-centre study.  325 
 326 
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FIGURE LEGENDS 413 
Figure 1 Schematic representation of the block experimental design. Each rectangle represents a 16 414 
sec period during which 4 pictures of the same category have been presented for 4 s each. 415 
Figure 2 Neuronal activation across the 6 ROIs for the contrast high- and low-calorie foods vs. 416 
objects. Regions are shown in sagittal, coronal and axial planes, rendered on the surface of a single-417 
subject template supplied by SPM8. Talairach coordinates are given (x, y, z) for the most 418 
significant voxel in the cluster. L = left hemisphere, R = right hemisphere. Colour corresponds to T-419 
scores.  420 
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Figure 3 Box plots displaying neuronal activation in each of the 6 ROIs in response to high-calorie 421 
foods (as an average of all 3 sessions) in each of the 4 subject groups (from left to right): NOC, 422 
non-obese controls; OC, obese controls; HWS, weight-stable patients with hypothalamic damage; 423 
HO, obese patients with hypothalamic damage. Light grey bars represent weight-stable groups 424 
(HWS+NOC), dark grey bars obese groups (HO+OC).  425 
Figure 4 (Supplementary) Box plots for integrated (AUC) GLP-1 (pmol/l), PYY (ng/ml), ghrelin 426 
(pg/ml) and insulin (mIU/ml) measurements in each of the 4 subject groups (from left to right): 427 
NOC, non-obese controls; OC, obese controls; HWS, weight-stable patients with hypothalamic 428 
damage; HO, obese patients with hypothalamic damage. Light grey bars represent weight-stable 429 
groups (HWS+NOC) dark grey bars obese groups (HO+OC). 430 
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